Skip to main content

DrugPatentWatch

DrugPatentWatch is a self-service biopharmaceutical intelligence platform that aggregates patent, pipeline, litigation, pricing, and sales data from primary sources across 134 countries, updated daily. Subscribers can search a global database of drug patents, monitor generic entry opportunities, access full litigation documents, and evaluate market entry strategies using historic sales figures. The platform includes an AI research assistant that answers questions with full citations, plus an automation suite that delivers custom alerts and dashboards.

Traction 1/10
Washington, United States · HQ
Founded 200342K+ followers
  • Data & Analytics
  • Software Only
  • Artificial Intelligence
Updated 7 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Pharmaceutical companies and investors rely on expensive boutique consulting firms for drug patent and market intelligence, which often deliver delayed, filtered reports built on stale public data. By the time quarterly reports arrive, market-moving events like ANDA filings or patent expirations have already occurred, and clients never receive the underlying raw data needed to run their own analyses.

Solution

DrugPatentWatch is a self-service biopharmaceutical intelligence platform that aggregates patent, pipeline, litigation, pricing, and sales data directly from primary sources across 134 countries, updating daily. Subscribers can search a global database of drug patents, monitor generic entry opportunities, access full litigation documents, and evaluate market entry strategies using historic sales figures. The platform includes an AI research assistant that answers questions with full citations, plus an automation suite that delivers custom alerts and dashboards. Unlike traditional analysts, DrugPatentWatch gives users direct access to raw data, allowing them to run their own queries, export datasets permanently, and avoid the high costs of bespoke consulting engagements.

Target Audience

Primary customers include pharmaceutical companies, generics manufacturers, biotech firms, and distributors across 70+ countries who need timely, verifiable intelligence for market entry, portfolio decisions, and competitive strategy.

Features

  • Global database covering patents, pipelines, litigation, and sales across 134 countries with 24/7 daily updates from primary sources including USPTO, FDA Orange Book, and ANDA filings
  • Patent litigation tracker with full complaints and court documents to study failed challenges and anticipate early generic entry
  • AI Deep Research Engine that synthesizes disparate sources with full citations for accuracy
  • Automation Suite with configurable alerts, monitoring, and custom dashboards
  • Raw data access with permanent export of full datasets in clean, structured formats
  • Patent expiry opportunity tracking with high-value drug monitoring (e.g., Keytruda 2028, Eliquis 2026, Ozempic 2032)
This profile is AI-generated and may contain inaccuracies.